Artivion | CRY - Interest Expense On Debt


Artivion reported $5.53M in Interest Expense on Debt for its fiscal quarter ending in December of 2025.





Interest Expense On Debt Change Date
Abbott USD 68M 26M Mar/2026
Accuray USD 2.88M 72K Dec/2024
AngioDynamics USD 102K 2K Sep/2025
Artivion USD 5.53M 589K Dec/2025
AtriCure USD 1.37M 42K Dec/2025
Baxter International USD 58M 14M Sep/2025
Becton, Dickinson and Co. USD 149M 4M Mar/2026
Boston Scientific USD 90M 0 Mar/2026
Edwards Lifesciences USD 35.9M 2.7M Dec/2025
Inogen 1.03M 384K Mar/2025
Integra LifeSciences USD 22.46M 1.21M Mar/2026
J&J USD 43M 25M Mar/2026
Mesa Laboratories USD 3.02M 180K Sep/2024
Orthofix International 4.68M 731K Sep/2025
Pfizer USD 671M 40M Mar/2026
ResMed USD 8.79M 14.55M Sep/2025
Stryker USD 46.29B 45.68B Mar/2026
Surmodics USD 884K 5K Sep/2024
Tandem Diabetes Care USD 1.15B 1.15B Mar/2026
Teleflex USD 25.72M 2.43M Mar/2026
Terumo JPY 1.53B 1.06B Mar/2026
Trinity Biotech USD 3.33M 50K Sep/2025